Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Kidney International Année : 2019

Dates et versions

inserm-02193816 , version 1 (24-07-2019)

Identifiants

Citer

K. Dahan, C. Johannet, E. Esteve, E. Plaisier, H. Debiec, et al.. Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody. Kidney International, 2019, 95 (1), pp.233-234. ⟨10.1016/j.kint.2018.08.045⟩. ⟨inserm-02193816⟩
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More